secwatch.observer — SEC 8-K summary
======================================

Issuer:     LISATA THERAPEUTICS, INC. (LSTA)
CIK:        0000320017
Form:       8-K
Filed at:   2025-06-10T23:59:59+00:00
Accession:  0000320017-25-000033
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lisata shareholders re-elect Azab, Klosk; approve ESPP, auditor, say-on-pay, one-year frequency
--------------------------------------------------------------------------------

- Re-elected Mohammad Azab (3,809,977 for) and Steven Klosk (3,788,000 for) as Class III directors to 2028.
- Approved amendment to 2017 ESPP increasing shares from 113,333 to 158,333 (3,523,229 for, 294,116 against, 378,495 abstain).
- Ratified Grant Thornton LLP as independent auditor for FY2025 (6,226,674 for, 64,171 against, 136,348 abstain).
- Non-binding advisory votes: approved executive compensation (3,496,571 for) and selected one-year frequency for future say-on-pay votes (3,967,202 for one year).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/320017/000032001725000033/0000320017-25-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/320017/000032001725000033/clbs-20250610.htm
  HTML page:      https://secwatch.observer/filing/0000320017-25-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer